USFDA gives nod for second opioid overdose reversal drug ReVive
HQ Team July 30, 2023: A not-for-profit US company, Harm Reduction Therapeutics’s ReVive has been allowed by the FDA to market its opioid.
Drugs
Health
Pharma
Drugs
Health
Pharma
FDA clears Emergent’s nasal spray for opioid overuse to sell at pharmacies
US-based Emergent BioSolutions announced that FDA had approved its nasal spray Narcan as an over-the-counter emergency treatment for opioid overuse.